2
N.O. Mahmoodi et al. / Ultrasonics Sonochemistry xxx (2014) xxx–xxx
reaction conditions, low reaction yields, and poor regioselectivity.
Therefore, development of a reliable and efficient method is still
required.
phases were dried out over Na2SO4, filtered, and concentrated in
vacuum to afford the title compound as near colorless oil that
maybe slowly solidified upon standing. The products were estab-
lished by their 1H NMR, 13C NMR, FT-IR and elemental analysis
data.
In assembling valuable chemical products, MCRs have several
advantages over traditional approaches, e.g. linear, iterative or
divergent synthesis. MCRs proceed easily to provide synthetic
products in good to excellent yields. Assuming the same yields
per step, the total yield of the convergent synthesis is considerable
higher than the corresponding linear synthesis. Reports about the
five-component coupling reaction in synthesis of functionalized
organic products are very rare [25]. Here, in contribution to our
previous work [26], a simple and efficient ultrasound-promoted
five-component synthesis of 1a-l with alkyl and benzyl linkages
at r. t. are describe.
Typical characteristic data for compound 1j, 1k and 1l are given
below:
2.2.1. 1,4-bis(((6-methyl-2-phenylpyrimidine-4-yl)oxy)methyl)
benzene (1j)
Pale yellow oil. yield 78%. IR (m
max/cmꢀ1): 1651 (C@N), 1252
(C-O). 1H NMR (400 MHz, CDCl3) (d/ppm): 8.15 (4H, d, J = 8.4 Hz,
ArAH), 7.60–7.70 (6H, m, ArAH), 7.17 (4H, s, benzylic-H), 6.19
(2H, s, H5 of pyrimidine), 4.86 (4H, s, AOCH2A), 2.46 (6H, s,
ACH3). 13C NMR (100 MHz, CDCl3) (d/ppm): 170.6 (C4 of pyrimi-
dine), 166.4 (C6 of pyrimidine), 162.1 (C2 of pyrimidine), 130.3–
136.0 (ArAC), 100.2 (C5 of pyrimidine), 47.5 (AOCH2A), 29.6
(ACH3). Molecular Weight: 474.56. Anal. Calcd. for C30H26N4O2:
C, 75.93; H, 5.52; N, 11.81%. Found C, 75.91; H, 5.50; N, 11.77%.
2. Experimental
2.1. Material and methods
Chemical materials were purchased from Merck, Aldrich, and
Fluka. FT-IR spectra were determined on a Shimadzu IR-470 spec-
trometer. Ultrasound device Astra 3D (9.5 L, 45 kHz frequency,
input power with heating, 305 W, number of transducers, 2) from
TECNO-GAZ was used. All 1H NMR and 13C NMR data were
recorded in CDCl3 using a Bruker Avance 400 and 100-MHz spec-
trometer. Chemical shifts are reported in ppm (d) using deuterated
solvents as internal references. Elemental analysis were made by a
Carlo – Erba EA1110 CNNO-S analyzer and agreed with the calcu-
lated values.
2.2.2. 1,4-bis(((2-phenyl-6-propylpyrimidine-4-yl)oxy)methyl)
benzene (1k)
Pale cream oil. yield 76%. IR (m
max/cmꢀ1). 1657 (C@N), 1252
(C-O). 1H NMR (400 MHz, CDCl3) (d/ppm): 8.14 (4H, d, J = 10.0 Hz,
ArAH), 7.73–7.87 (6H, m, ArAH), 7.00 (4H, s, benzylic-H), 6.09
(2H, s, H5 of pyrimidine), 5.24 (4H, s, AOCH2A), 2.73 (4H, t,
J = 15.8 Hz, ACH2A), 1.63–1.82 (4H, m, ACH2A), 0.95 (6H, t,
J = 15.2 Hz, ACH3). 13C NMR (100 MHz, CDCl3) (d/ppm): 172.47
(C4 of pyrimidine), 172.3 (C6 of pyrimidine), 164.5 (C2 of pyrimi-
dine), 127.4–136.3 (ArAC), 107.4 (C5 of pyrimidine), 57.8 (AOCH2-
A), 43.7 (ACH2A), 26.0 (ACH2A), 22.6 (ACH3). Molecular Weight:
530.67. Anal. Calcd. for C34H34N4O2: C, 76.95; H, 6.46; N, 10.56%.
Found C, 76.93; H, 6.51; N, 10.53%.
2.2. General procedure for the synthesis of 1,n-bis((6-alkyl or phenyl-
2-phenylpyrimidine-4-yl) oxy) alkane or methyl benzene derivatives
(1a-l)
Benzamidine hydrochloride (1, 31.7 mg, 0.203 mmol), b-ketoes-
ter derivatives (2, 0.184 mmol) and powdered K2CO3 (63.7 mg,
0.461 mmol), were dissolved in DMF (1.5 mL), followed by
dihaloalkane (3, 0.23 mmol) in a 25 mL conical flask. Then the mix-
ture was irradiated in the water bath of an ultrasonic cleaner at r. t.
for the duration as shown in Table 2; and reaction progress was
monitored by TLC. Upon end of the reaction, the reaction mixture
was diluted with EtOAc (10 mL), and washed with sat. aq NaHCO3
(10 mL) and brine (10 mL). The combined aqueous phases were
back-extracted with EtOAc (5 mL), and the combined organic
2.2.3. 1,4-bis(((2,6-diphenylpyrimidine-4-yl)oxy)methyl)benzene (1l)
Pale cream oil. yield 74%. IR (m
max/cmꢀ1): 1621 (C@N), 1253
(CAO). 1H NMR (400 MHz, CDCl3) (d/ppm): 8.27 (4H, d, J = 8.8 Hz,
ArAH), 7.84 (4H, d, J = 7.2 Hz, ArAH), 7.54–7.65 (8H, m, ArAH),
7.39–7.45 (6H, m, ArAH and H5 of pyrimidine), 7.12 (4H, s, ben-
zylic-H), 5.49 (4H, s, AOCH2A). 13C NMR (100 MHz, CDCl3)
(d/ppm): 173.9 (C4 of pyrimidine), 172.1 (C6 of pyrimidine),
164.1 (C2 of pyrimidine), 127.1–138.4 (ArAC), 104.6 (C5 of pyrim-
idine), 45.9 (AOCH2A). Molecular Weight: 598.71. Anal. Calcd. for
Table 1
Effect of solvent on the reaction of benzamidine hydrochloride 2 with ethyl acetoacetate 3a and 1,5-dibromopentane 4b.a
NH
Ph
N
O
O
N
O
O
Ph
. HCl
NH2
4b
Br
Br
(CH2)5
2
2
Ph
N
+
OEt
N
K2CO3, Solvent
Ultrasound, rt.
2
3a
1d
Entry
Solvent
Time (h)
Yieldb (%)
1
2
3
4
5
6
Water
EtOH
MeOH
THF
Toluene
DMF
2
1
1
1.5
1.5
0.5
<5
67c
59c
<20
<15
95
a
All reactions were carried out by using 2 (0.203 mmol), 3a (0.184 mmol), 4b (0.230 mmol), and powdered K2CO3 (0.461 mmol) under ultrasound
condition at 25 °C.
b
Isolated yield.
c
Trace conversion to bis-pyrimidine product; reaction stalls at the pyrimidinone intermediate and the reported yields refer to pyrimidinones.
Please cite this article in press as: N.O. Mahmoodi et al., Ultrasound-promoted one-pot five-components synthesis of biologically active novel bis((6-alkyl
or phenyl-2-phenylpyrimidine-4-yl) oxy) alkane or methyl benzene derivatives, Ultrason. Sonochem. (2014), http://dx.doi.org/10.1016/